Malignant Cardiac Tumors: Diagnosis and Treatment
- 1 July 2015
- journal article
- review article
- Published by Taylor & Francis in Future Cardiology
- Vol. 11 (4) , 485-500
Abstract
Primary malignant cardiac tumors are represented by sarcomas and non-Hodgkin lymphomas. They are rare, affect mostly patients in the fourth decade of life and have a severe prognosis. Both the diagnosis and the treatment require a multidisciplinary approach, and the cardiologist plays a central role both in the diagnosis and in the follow-up. The prognosis may be improved by a careful planning of surgery and by the use of multimodality treatment, including complementary chemotherapy and radiation therapy. A strict follow-up must be planned even after apparently complete cure.Keywords
This publication has 77 references indexed in Scilit:
- Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regionsAnnals of Oncology, 2012
- Angiosarcoma: State of the art and perspectivesCritical Reviews in Oncology/Hematology, 2011
- Primary cardiac lymphomaInternational Journal of Cardiology, 2011
- Computed tomography of cardiac and pericardiac massesJournal of Cardiovascular Computed Tomography, 2011
- Correlation Between Glycolytic Phenotype and Tumor Grade in Soft-Tissue Sarcomas by 18F-FDG PETJournal of Nuclear Medicine, 2010
- Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer, 2008
- Prognostic factors in soft tissue sarcomas: a study of 395 patientsEuropean Journal of Surgical Oncology, 2002
- Primary cardiac sarcomas: an immunohistochemical and grading study with long‐term follow‐up of 24 casesHistopathology, 1999
- Primary right atrial fibrosarcoma diagnosed by endocardial biopsyAmerican Heart Journal, 1996